4 Feb 2013 07:00
4 February 2013
TyraTech, Inc.
(the "Company" or "TyraTech")
TyraTech Announces first patent granted for its Extend™ Technology
TyraTech Inc (AIM: TYR and TYRU), a life sciences company focusing on natural pest control and healthcare products, has received notification that its Extend™ patent has been granted in South Africa. The patent proves the proprietary nature of the Company's technology platform and protects a broad range of synergistic combinations of natural and synthetic compounds, which can be used against a variety of target pests. The patent has a 20-year term, which expires in March 2029.
Bruno Jactel, CEO, said: "These patents are important to demonstrate the synergy between our blends and synthetic compounds and that we are uniquely able to improve the efficacy while reducing the environmental footprint of synthetic pesticides. This will support both the strategy of ENVANCE Technologies, our joint venture with AMVAC Chemical Corporation and our animal health strategy."
For further information please contact:
TyraTech Inc. | ||
Alan Reade, Executive Chairman | Tel: +1 919 415 4310 | |
Bruno Jactel Chief Executive Officer | Tel: +1 919 415 4340 | |
N+1 Singer, Nominated Adviser and Joint Broker | Tel: +44 20 7496 3000 | |
Aubrey Powell / Alex Wright | ||
First Columbus LLP, Joint Broker | Tel: +44 20 3002 2070 | |
Chris Crawford | ||
Walbrook, Financial PR and IR Bob Huxford /Helen Westaway (Public Relations)
| Tel + 44 20 7933 8792 tyratech@walbrookpr.com |